Unique Ingredient Identifier 7CVR7L4A2D is listed as a ingredient substance
| RN | 9050-36-6 |
| EC | 232-940-4 |
| NCIT | C68474 |
| RXCUI | 1363050 |
| MF | Polymer substance not supported |
UNII 7CVR7L4A2D MALTODEXTRIN is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| ORAL | CAPSULE | 100 MG |
| ORAL | CAPSULE (IMMED./COMP. RELEASE) | 75 MG |
| ORAL | FILM, SOLUBLE | 3.2 MG |
| ORAL | GRANULE, FOR SUSPENSION | 238.1 MG |
| ORAL | POWDER | 729 MG/1PKT |
| ORAL | POWDER | 729 MG/1SCP |
| ORAL | POWDER, FOR SUSPENSION | 190 MG/1SCP |
| ORAL | SOLUTION | 145.1 mg |
| ORAL | SOLUTION | 45 MG/5ML |
| ORAL | SUSPENSION | 6.25 MG/5ML |
| ORAL | SUSPENSION | 0.5 mg/1mL |
| ORAL | TABLET | 102.35 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 292 MG |
| ORAL | TABLET, CHEWABLE | 4.2 MG |
| ORAL | TABLET, COATED | 5.6 MG |
| ORAL | TABLET, EFFERVESCENT, FOR SOLUTION | 400.1 MG |
| ORAL | TABLET, EXTENDED RELEASE | 165.18 MG |
| ORAL | TABLET, FILM COATED | NA |
| ORAL | TABLET, ORALLY DISINTEGRATING | 1.88 MG |
| ORAL | TABLET, SUSTAINED ACTION | 72.5 MG |
| ORAL | TABLET, SUSTAINED ACTION, COATED | NA |